Nanjing Iaso Biotechnology Co., Ltd.

This is an early-stage study testing a new CAR T-cell therapy called UB-VV410 in adults with severe, treatment-resistant lupus or lupus nephritis (kidney inflammation from lupus). The main goals are to find the safest and most effective dose and to check for side effects. The stu…

This early-stage study is testing the safety and initial effectiveness of an investigational cell therapy called UB-VV400, given alone and together with the drug rapamycin. It is for adults with aggressive B-cell lymphoma that has come back or not responded to other treatments, i…